MORGAN STANLEY - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 46 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$420,845
+402.4%
711,969
+231.3%
0.00%
Q4 2022$83,767
-83.2%
214,901
-77.0%
0.00%
Q3 2022$498,000
-64.5%
933,572
+5.3%
0.00%
Q2 2022$1,402,000886,7160.00%
Other shareholders

There were no reported owners of TONIX PHARMACEUTICALS HLDG C in Q3 2022.

NameSharesValueWeighting ↓
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders